Stay updated on Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial

Sign up to get notified when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4 instead of v3.5.3, marking a new build of the record history page. This is a metadata update that signals an underlying platform change rather than changes to the study data or visible content.
    Difference
    0.1%
    Check dated 2026-05-16T10:22:34.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page footer’s interface revision indicator was updated from v3.5.2 to v3.5.3, reflecting a site/version change rather than an update to the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-25T05:24:57.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T03:50:14.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the record history, and the previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-20T07:01:04.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the page history. Revision v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-05T18:58:26.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    The Record History shows multiple submissions updating study status, recruitment status, and core study details such as eligibility criteria, locations, and outcome measures.
    Difference
    0.1%
    Check dated 2026-02-26T15:13:20.000Z thumbnail image

Stay in the know with updates to Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.